Cara Community Biotechs: TCR2 Thera
TCR2 Therapeutics (NASDAQ: TCRR) reviewed 10-15-2020 Market Cap: $689 Million (USD) Share Price: $20.70 (USD) Shares outstanding: 33,344,021 as of 3 Aug 2020 Cash & cash equivalents: $49.7 M (USD) as of 30 Jun 2020 Debt: None. Company funds via sales of common and preferred stock Insiders: Own 5.6% Institutional: